Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5638.5000 29.00 (0.52%)

NSE Dec 02, 2025 15:31 PM

Near 52W High of ₹5868.00

Volume: 54,507

Alkem Laboratories Ltd.

05 Feb 2022

5638.50

0.52%

Alkem Labs (HOLD): Strong domestic growth; weak margins

Hold: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Robust traction in India formulations (+20% YoY) during Q3, partly offset by a 7% decline in US generic revenue

Number of FII/FPI investors increased from 551 to 589 in Sep 2025 qtr.